MedTrace Logo

Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine

NCT01973205 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2015-06-11

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine

Conditions

  • Acute Migraine

Interventions

DRUG

Acetaminophen 250 mg and Aspirin 250 mg

2 tablets each containing Acetaminophen 250 mg and Aspirin 250 mg

DRUG

Placebo

2 placebo tablets matching acetaminophen 250 mg and aspirin 250 mg tablets

Sponsors & Collaborators

Principal Investigators

  • Clinical Project Lead · Novartis Consumer Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01973205 on ClinicalTrials.gov